CNS Pharmaceuticals
CNSP
CNSP
6 hedge funds and large institutions have $425K invested in CNS Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$24K | |
| 2 | -$5.4K | |
| 3 | -$576 | |
| 4 |
Morgan Stanley
New York
|
-$76 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$63 |